Sotera Health Co's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 13/78 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 18.93.In the medium term, the stock price is expected to remain stable.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Sotera Health Co's Score
Industry at a Glance
Industry Ranking
13 / 78
Overall Ranking
69 / 4589
Industry
Healthcare Providers & Services
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
9
analysts
Buy
Current Rating
18.929
Target Price
+14.03%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Sotera Health Co Highlights
StrengthsRisks
Sotera Health Company is a global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. The Company’s segments include Sterigenics, Nordion and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets using three technologies: gamma irradiation, ethylene oxide (EO) processing and E-beam irradiation. Nordion business is a global provider of Co-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. In addition, Nordion is a global provider of gamma irradiation systems. Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries.
Fairly Valued
The company’s latest PE is 86.01, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 259.09M shares, decreasing 11.46% quarter-over-quarter.
Sotera Health Company is a global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. The Company’s segments include Sterigenics, Nordion and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets using three technologies: gamma irradiation, ethylene oxide (EO) processing and E-beam irradiation. Nordion business is a global provider of Co-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. In addition, Nordion is a global provider of gamma irradiation systems. Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries.
Ticker SymbolSHC
CompanySotera Health Co
CEOPetras (Michael B)
Websitehttps://soterahealth.com/
FAQs
What is the current price of Sotera Health Co (SHC)?
The current price of Sotera Health Co (SHC) is 16.800.
What is the symbol of Sotera Health Co?
The ticker symbol of Sotera Health Co is SHC.
What is the 52-week high of Sotera Health Co?
The 52-week high of Sotera Health Co is 17.780.
What is the 52-week low of Sotera Health Co?
The 52-week low of Sotera Health Co is 9.530.
What is the market capitalization of Sotera Health Co?
The market capitalization of Sotera Health Co is 4.77B.
What is the net income of Sotera Health Co?
The net income of Sotera Health Co is 44.34M.
Is Sotera Health Co (SHC) currently rated as Buy, Hold, or Sell?
According to analysts, Sotera Health Co (SHC) has an overall rating of Buy, with a price target of 18.929.
What is the Earnings Per Share (EPS TTM) of Sotera Health Co (SHC)?
The Earnings Per Share (EPS TTM) of Sotera Health Co (SHC) is 0.195.